Fresenius Medical Care to acquire NxStage Medical for $2 billion

Fresenius Medical Care signed an agreement to acquire NxStage Medical, a U.S. medical technology company, for approximately $2.0 billion, to strengthen its home dialysis and critical care presence.

“The acquisition supports our 2020 strategic initiative of driving growth in the core business with innovation, better clinical outcomes through Care Coordination and improving the patient experience.”sec.gov

• 1 source
• sec.govExhibit 99.2Aug 7, 2017

Summarized from public sources; check the original articles before acting on it.